Abstract:BACKGROUND:Thrombolytic therapy with tissue plasminogen activator (tPA) benefits patients with acute ischemic stroke. However, tPA increases the risk for intracerebral bleeding and enhances post-ischemic neuronal injury if administered 3-4 hours after stroke. Therefore, combination therapies with tPA and neuroprotective agents have been considered to increase tPA's therapeutic window and reduce toxicity. The anticoagulant factor protein S (PS) protects neurons from hypoxic/ischemic injury. PS also inhibits N-methyl-D-aspartate (NMDA) excitotoxicity by phosphorylating Bad and Mdm2 which blocks the downstream steps in the intrinsic apoptotic cascade. To test whether PS can protect neurons from tPA toxicity we studied its effects on tPA/NMDA combined injury which in contrast to NMDA alone kills neurons by activating the extrinsic apoptotic pathway. Neither Bad nor Mdm2 which are PS's targets and control the intrinsic apoptotic pathway can influence the extrinsic cascade. Thus, based on published data one cannot predict whether PS can protect neurons from tPA/NMDA injury by blocking the extrinsic pathway. Neurons express all three TAM (Tyro3, Axl, Mer) receptors that can potentially interact with PS. Therefore, we studied whether PS can activate TAM receptors during a tPA/NMDA insult.RESULTS:We show that PS protects neurons from tPA/NMDA-induced apoptosis by suppressing Fas-ligand (FasL) production and FasL-dependent caspase-8 activation within the extrinsic apoptotic pathway. By transducing neurons with adenoviral vectors expressing the kinase-deficient Akt mutant AktK179A and a triple FKHRL1 Akt phosphorylation site mutant (FKHRL1-TM), we show that Akt activation and Akt-mediated phosphorylation of FKHRL1, a member of the Forkhead family of transcription factors, are critical for FasL down-regulation and caspase-8 inhibition. Using cultured neurons from Tyro3, Axl and Mer mutants, we show that Tyro3, but not Axl and Mer, mediates phosphorylation of FHKRL1 that is required for PS-mediated neuronal protection after tPA/NMDA-induced injury.CONCLUSIONS:PS blocks the extrinsic apoptotic cascade through a novel mechanism mediated by Tyro3-dependent FKHRL1 phosphorylation which inhibits FasL-dependent caspase-8 activation and can control tPA-induced neurotoxicity associated with pathologic activation of NMDA receptors. The present findings should encourage future studies in animal stroke models to determine whether PS can increase the therapeutic window of tPA by reducing its post-ischemic neuronal toxicity.

Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain.

Tissue-type Plasminogen Activator (tpa) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate

Cerebral Ischemic Reperfusion Injuries (CIRI)

Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells.

PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells.

Tissue-Type Plasminogen Activator Has A Neuroprotective Effect In The Ischemic Brain Mediated By Neuronal Tnf-Alpha

Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.

Tissue-type Plasminogen Activator Induces Synaptic Vesicle Endocytosis in Cerebral Cortical Neurons.

Tissue-type Plasminogen Activator Protects Neurons from Excitotoxin-Induced Cell Death Via Activation of the ERK 1/2–CREB–ATF3 Signaling Pathway

Reprint of: Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival

Tissue-Type Plasminogen Activator Regulates the Neuronal Uptake of Glucose in the Ischemic Brain

The Plasminogen Activation System Promotes Dendritic Spine Recovery and Improvement in Neurological Function After an Ischemic Stroke

Tissue-type Plasminogen Activator and the Low-Density Lipoprotein Receptor–related Protein Induce Akt Phosphorylation in the Ischemic Brain

Tissue-Type Plasminogen Activator Triggers the Synaptic Vesicle Cycle in Cerebral Cortical Neurons

Tissue-Type Plasminogen Activator Mediates Neuronal Detection and Adaptation to Metabolic Stress

The Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons

Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release

FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury

Protein S Blocks the Extrinsic Apoptotic Cascade in Tissue Plasminogen Activator/n-Methyl D-aspartate-treated Neurons Via Tyro3-Akt-FKHRL1 Signaling Pathway

The regulatory effect of tissue plasminogen activator involved in central nervous insult